In addition, the combined diagnosis of XRCC4, PARP1, and excision repair cross-complementation group 1 (ERCC1) has demonstrated considerable predictive capability in assessing the risk of breast cancer metastasis [78]. The gene discussed is XRCC4; the disease is breast cancer.